101
IRUS TotalDownloads
Altmetric
Gene therapy for cystic fibrosis: recent progress and current aims
File | Description | Size | Format | ||
---|---|---|---|---|---|
Review - Gene therapy for CF 2015.docx | Accepted version | 80.67 kB | Microsoft Word | View/Open | |
Figures.ppt | Accepted version | 334.5 kB | Microsoft Powerpoint | View/Open | |
Title: | Gene therapy for cystic fibrosis: recent progress and current aims |
Authors: | Paul-Smith, MC Bell, RV Alton, WE Alton, EWFW Griesenbach, U |
Item Type: | Journal Article |
Issue Date: | 6-May-2016 |
Date of Acceptance: | 18-Apr-2016 |
URI: | http://hdl.handle.net/10044/1/32253 |
DOI: | https://dx.doi.org/10.1080/21678707.2016.1180974 |
ISSN: | 2167-8707 |
Publisher: | Taylor and Francis |
Start Page: | 649 |
End Page: | 658 |
Journal / Book Title: | Expert Opinion on Orphan Drugs |
Volume: | 4 |
Issue: | 6 |
Copyright Statement: | © 2016 Taylor & Francis. This is an Author's Accepted Manuscript of an article published in Expert Opinion on Orphan Drugs, available online at: http://dx.doi.org/10.1080/21678707.2016.1180974 |
Sponsor/Funder: | Medical Research Council (MRC) Cystic Fibrosis Trust |
Funder's Grant Number: | MR/J014699/1 VIA 013 |
Keywords: | Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Cystic fibrosis gene therapy lung viral vector non-viral vector TRANSMEMBRANE CONDUCTANCE REGULATOR LONG-TERM SAFETY NASAL POTENTIAL DIFFERENCE CHLORIDE TRANSPORT DEFECT AIRWAY EPITHELIAL-CELLS PLURIPOTENT STEM-CELLS PHASE 2B TRIAL RECOMBINANT ADENOVIRUS LENTIVIRAL VECTOR CFTR GENE |
Publication Status: | Published |
Appears in Collections: | National Heart and Lung Institute |